Filing Details
- Accession Number:
- 0001551986-18-000033
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-09-14 18:58:46
- Reporting Period:
- 2018-09-14
- Accepted Time:
- 2018-09-14 18:58:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1551986 | Innovate Biopharmaceuticals Inc. | INNT | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1721749 | P. Christopher Prior | C/O Innovate Biopharmaceuticals, Inc., 8480 Honeycutt Road, Suite 120 Raleigh NC 27615 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-09-14 | 200 | $5.82 | 2,009 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
